Search results
MRK Stock Sees Surge of Approximately 1.30% in Last Five Days – Knox Daily
Knox Daily· 2 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Merck & Co Inc shares valued at $492,135,715 ...
Analyst Report: Merck & Co., Inc.
Morningstar Research via Yahoo Finance· 2 days agoMerck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology ...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoWelcome to the Merck & Co. Q1 sales and earnings conference call. [Operator instructions] This call is being recorded. If you have any objections, you...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 2 days agoRAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway ...
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters via Yahoo Finance· 2 days agoMerck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's ...
Merck: Q1 Earnings Snapshot
Houston Chronicle· 2 days agoRAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway, New Jersey-based company ...
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 2 days agoSo it might be obvious that you need to consider debt, when you think about how risky any given...
Merck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-market
RTT News· 2 days agoDrug major Merck & Co., Inc. (MRK), while reporting higher first-quarter earnings, above market estimates, on Thursday raised its fiscal 2024 adjusted earnings and sales view.
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? - Immutep (NASDAQ:IMMP)
Benzinga· 3 days agoImmutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line...
